Clinical Trials
29 trialsFiReNEN
IRCCS San Raffaele
Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors.
IRCCS San Raffaele
Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014
AHS Cancer Control Alberta
Registry on NEN Patients and COVID-19
European Institute of Oncology
Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
GICCA
Leiden University Medical Center
Camune
University Hospital, Strasbourg, France
Single-cell Sequencing and Establishment of Models in Neuroendocrine Neoplasm
Fudan University
Neuroendocrine Neoplasm Based on Multi-omics Integrated Analysis
Fudan University
PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment
University of Warmia and Mazury
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
British Columbia Cancer Agency
MONET
European Institute of Oncology
Image-Enhanced Endoscopy in the Gastrointestinal Tract
King's College Hospital NHS Trust
Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT
Sheba Medical Center
Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia
University of Aarhus
PVNET
Royal Free Hospital NHS Foundation Trust
RMPanNET
Fudan University
Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors
Fox Chase Cancer Center
TANGO
University Hospital, Brest
VOLUNET
Hospices Civils de Lyon
Psychosocial Screening for Neuroendocrine Tumor Patients
Peking University
Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms
Peking University
PROGRESS
Uppsala University
Identification of Biomarker Profiles GEP-NEN Patients
University Hospital Schleswig-Holstein
Heart/Mediastinal Ratio Study for Potential Equivalence of Heart/Mediastinal Ratios at One and Two Hours to the Traditional Heart/Mediastinal Ratio Obtained at Four Hours
Nuclear Medicine Consultants, Inc.
NEO-LEBE
University of Jena
ProGRP, CgA, NSE and TUM2-PK in in Patients With Neuroendocrine Tumors
Hadassah Medical Organization
Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors
Hadassah Medical Organization
11C-Acetate PET/CT Non-FDG-Avid Tumors
Tel-Aviv Sourasky Medical Center